-rsen
An antisense oligonucleotide: a short strand of DNA-like chemistry that binds a gene's messenger RNA to block or redirect it.
- Drugs ending in -rsen: 88
- Approved somewhere: 10
- With a US drug page: 16
- Stem
- -rsen
- Class
- Antisense oligonucleotides, which bind a gene's RNA to block or alter it
- Sub-stems
- -nersen
- Most common targets
- Dystrophin pre-mRNA (7), Transthyretin mRNA (3), Intercellular adhesion molecule-1 mRNA 3'UTR (2), Protein kinase C alpha mRNA 3'UTR (2), Clusterin mRNA (2), Bcl-2 mRNA (2), Heat shock protein beta-1 (HSP27) mRNA (2), microRNA-155 (2)
Approved and clinical-stage drugs in ChEMBL whose names ending in -rsen or one of its sub-stems, matched by spelling; those with a US drug page link to it.
| Acts on | |||
|---|---|---|---|
| Casimersen | Approved | Dystrophin pre-mRNA | Dystrophin pre-mRNA positive modulator |
| Eplontersen sodium | Approved | Transthyretin mRNA | Transthyretin mRNA antisense inhibitor |
| Eteplirsen | Approved | Dystrophin pre-mRNA | Dystrophin pre-mRNA positive modulator |
| Golodirsen | Approved | Dystrophin pre-mRNA | Dystrophin pre-mRNA positive modulator |
| Inotersen | Approved | Transthyretin mRNA | Transthyretin mRNA antisense inhibitor |
| Mipomersen | Approved | Apo-B 100 mRNA | Apo-B 100 mRNA antisense inhibitor |
| Tofersen | Approved | SOD1 mRNA | SOD1 mRNA antisense inhibitor |
| Viltolarsen | Approved | Dystrophin pre-mRNA | Dystrophin pre-mRNA positive modulator |
| Donidalorsen | Phase 3 | — | — |
| Eplontersen | Phase 3 | Transthyretin mRNA | Transthyretin mRNA antisense inhibitor |
| Olezarsen | Phase 3 | Apolipoprotein C-III mRNA | Apolipoprotein C-III mRNA antisense inhibitor |
| Donidalorsen sodium | Phase 2 | — | — |
| Olezarsen sodium | Phase 1 | — | — |
| Volanesorsen | Approved | Apolipoprotein C-III mRNA 3'UTR | Apolipoprotein C-III mRNA 3'UTR antisense inhibitor |
| Alicaforsen | Phase 3 | Intercellular adhesion molecule-1 mRNA 3'UTR | Intercellular adhesion molecule-1 mRNA 3'UTR antisense inhibitor |
| Anivamersen | Phase 3 | — | — |
| Aprinocarsen | Phase 3 | Protein kinase C alpha mRNA 3'UTR | Protein kinase C alpha mRNA 3'UTR antisense inhibitor |
| Custirsen | Phase 3 | Clusterin mRNA | Clusterin mRNA antisense inhibitor |
| Custirsen sodium | Phase 3 | Clusterin mRNA | Clusterin mRNA antisense inhibitor |
| Drisapersen | Phase 3 | Dystrophin pre-mRNA | Dystrophin pre-mRNA positive modulator |
| Mongersen sodium | Phase 3 | SMAD-7 mRNA | SMAD-7 mRNA antisense inhibitor |
| Oblimersen sodium | Phase 3 | Bcl-2 mRNA | Bcl-2 mRNA antisense inhibitor |
| Pelacarsen | Phase 3 | LPA mRNA | LPA mRNA antisense inhibitor |
| Trabedersen | Phase 3 | Transforming growth factor beta-2 mRNA | Transforming growth factor beta-2 mRNA antisense inhibitor |
| Apatorsen | Phase 2 | Heat shock protein beta-1 (HSP27) mRNA | Heat shock protein beta-1 (HSP27) mRNA antisense inhibitor |
| Brogidirsen | Phase 2 | — | — |
| Cibrigirsen | Phase 2 | — | — |
| Cimderlirsen sodium | Phase 2 | — | — |
| Cobomarsen | Phase 2 | microRNA-155 | microRNA-155 inhibitor |
| Cofirasersen | Phase 2 | Amiloride-sensitive sodium channel, ENaC mRNA | Amiloride-sensitive sodium channel, ENaC mRNA antisense inhibitor |
| Danvatirsen | Phase 2 | STAT-3 mRNA 3'UTR | STAT-3 mRNA 3'UTR antisense inhibitor |
| Evazarsen | Phase 2 | — | — |
| Fesomersen sodium | Phase 2 | — | — |
| Gataparsen | Phase 2 | Survivin mRNA | Survivin mRNA antisense inhibitor |
| Lademirsen | Phase 2 | microRNA 21 | microRNA 21 antisense inhibitor |
| Monarsen | Phase 2 | — | — |
| Mulnitorsen | Phase 2 | — | — |
| Oblimersen | Phase 2 | Bcl-2 mRNA | Bcl-2 mRNA antisense inhibitor |
| Prexigebersen | Phase 2 | Growth factor receptor-bound protein 2 mRNA | Growth factor receptor-bound protein 2 mRNA antisense inhibitor |
| Remlarsen | Phase 2 | — | — |
| Sapablursen | Phase 2 | Transmembrane protease serine 6 mRNA | Transmembrane protease serine 6 mRNA antisense inhibitor |
| Sefaxersen sodium | Phase 2 | — | — |
| Sepofarsen | Phase 2 | CEP290 mRNA | CEP290 mRNA positive modulator |
| Suvodirsen | Phase 2 | Dystrophin pre-mRNA | Dystrophin pre-mRNA positive modulator |
| Tonlamarsen | Phase 2 | — | — |
| Vesleteplirsen | Phase 2 | — | — |
| Vupanorsen | Phase 2 | Angiopoietin like 3 (ANGPTL3) mRNA, ASGR1 | Angiopoietin like 3 (ANGPTL3) mRNA antisense inhibitor |
| Beclanorsen | Phase 1 | — | — |
| Cepadacursen sodium | Phase 1 | — | — |
| Cimdelirsen | Phase 1 | — | — |
| Eluforsen | Phase 1 | — | — |
| Evazarsen sodium | Phase 1 | — | — |
| Fesomersen | Phase 1 | — | — |
| Frenlosirsen | Phase 1 | — | — |
| Obeversen | Phase 1 | — | — |
| Obeversen sodium | Phase 1 | — | — |
| Pelacarsen sodium | Phase 1 | — | — |
| Sapablursen sodium | Phase 1 | — | — |
| Sefaxersen | Phase 1 | — | — |
| Suvodirsen sodium | Phase 1 | Dystrophin pre-mRNA | Dystrophin pre-mRNA positive modulator |
| Tonlamarsen sodium | Phase 1 | — | — |
| Vupanorsen sodium | Phase 1 | Angiopoietin like 3 (ANGPTL3) mRNA, ASGR1 | Angiopoietin like 3 (ANGPTL3) mRNA antisense inhibitor |
| Aganirsen | — | Insulin receptor substrate 1 mRNA | Insulin receptor substrate 1 mRNA antisense inhibitor |
| Alicaforsen sodium | — | Intercellular adhesion molecule-1 mRNA 3'UTR | Intercellular adhesion molecule-1 mRNA 3'UTR antisense inhibitor |
| Apatorsen sodium | — | Heat shock protein beta-1 (HSP27) mRNA | Heat shock protein beta-1 (HSP27) mRNA antisense inhibitor |
| Aprinocarsen sodium | — | Protein kinase C alpha mRNA 3'UTR | Protein kinase C alpha mRNA 3'UTR antisense inhibitor |
| Cobomarsen sodium | — | microRNA-155 | microRNA-155 inhibitor |
| Danvatirsen sodium | — | STAT-3 mRNA 3'UTR | STAT-3 mRNA 3'UTR antisense inhibitor |
| Lademirsen sodium | — | microRNA 21 | microRNA 21 antisense inhibitor |
| Nusinersen | Approved | SMN2 pre-mRNA | SMN2 pre-mRNA positive modulator |
| Zilganersen | Phase 3 | — | — |
| Zilganersen sodium | Phase 1 | — | — |
| Tominersen | Phase 3 | Huntingtin mRNA | Huntingtin mRNA antisense inhibitor |
| Cenersen | Phase 2 | p53 mRNA | p53 mRNA antisense inhibitor |
| Cenersen sodium | Phase 2 | p53 mRNA | p53 mRNA antisense inhibitor |
| Lexanersen | Phase 1 | — | — |
| Obudanersen | Phase 1 | — | — |
| Obudanersen sodium | Phase 1 | — | — |
| Rovanersen | Phase 1 | — | — |
| Rovanersen sodium | Phase 1 | — | — |
| Rugonersen | Phase 1 | — | — |
| Rugonersen sodium | Phase 1 | — | — |
| Salanersen | Phase 1 | — | — |
| Tadnersen sodium | Phase 1 | — | — |
| Ulefnersen | Phase 1 | — | — |
| Ulefnersen sodium | Phase 1 | — | — |
| Zorevunersen | Phase 1 | — | — |
| Zorevunersen sodium | Phase 1 | — | — |
Stem from WHO, The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances (2024); description written by Arca. Drugs, stages, targets and mechanisms from ChEMBL (CC BY-SA 3.0). WHO